Mitsuhiro Takenoyama
National Hospital Organization Kyushu Cancer Center · 340 works · 5,805 citations · h-index 41
Top works
- Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
- Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations
- Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non–Small-Cell Lung Cancer
- Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status
- Clinical Efficacy and Safety of Nivolumab: Results of a M ulticenter, Op e n-label, Single-a r m, Japanese Phase II study in Mal i gnant Pleural Meso t helioma (MERIT)
- Unfavorable Prognosis of Patients With Stage II Non-small Cell Lung Cancer Associated With Macroscopic Nodal Metastases
- Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K-ras, MET, and Hepatocyte Growth Factor Status
- Postoperative Prognosis in Patients With Non–Small Cell Lung Cancer With Synchronous Ipsilateral Intrapulmonary Metastasis
- First Case of Combined Small-Cell Lung Cancer with Adenocarcinoma Harboring EML4 - ALK Fusion and an Exon 19 EGFR Mutation in Each Histological Component
- Crizotinib Can Overcome Acquired Resistance to CH5424802: Is Amplification of the MET Gene a Key Factor?
- Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer
- Pleural retraction and intra-tumoral air-bronchogram as prognostic factors for stage I pulmonary adenocarcinoma following complete resection.
- Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib
- Survival and prognostic factors of surgically resected T4 non-small cell lung cancer
- An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene
- Pulmonary Resection for Metastatic Colorectal Cancer
- A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)
- Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors
- Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer
- Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer